白血病患者RASSF1A基因甲基化状态及其临床意义

检验医学 ›› 2012, Vol. 27 ›› Issue (7): 554-556.

白血病患者RASSF1A基因甲基化状态及其临床意义

陈卫群,黄琛,詹喜炎,刘水逸,余洁,张红梅,卢忠心

1. 武汉市中心医院中心实验室，湖北武汉 430014；2. 武汉市中心医院检验科，湖北武汉 430014

收稿日期:2012-05-18 修回日期:2012-02-29 出版日期:2012-07-30 发布日期:2012-07-05
通讯作者: 卢忠心，联系电话：027-82211532。
作者简介:陈卫群，女，1968年生，副主任技师，主要从事肿瘤标志物与基因治疗研究。
基金资助:
国家自然科学基金（81071921）；湖北省自然科学基金（2010CDB09002）；武汉市卫生局基金（WX08D11）

RASSF1A gene methylation and its clinical significance in leukemia patients

1. Central Laboratory，the Central Hospital of Wuhan，Hubei Wuhan 430014，China；2. Department of Clinical Laboratory，the Central Hospital of Wuhan，Hubei Wuhan 430014，China

Received:2012-05-18 Revised:2012-02-29 Online:2012-07-30 Published:2012-07-05

摘要/Abstract

摘要： 目的　研究白血病患者骨髓中Ras相关区域家族1A（RASSF1A）基因启动子甲基化状态及其临床意义。方法　采用甲基化特异性聚合酶链反应（MS- PCR）检测86例白血病患者和60例非白血病患者对照组骨髓中RASSF1A基因启动子的甲基化状况，分析不同白血病类型之间的差异。结果　86例白血病患者中，有12例（13.95%）RASSF1A基因启动子甲基化，而60例非白血病患者骨髓均未检测到甲基化，二者比较差异均有统计学意义（P＜0.05）。淋巴系白血病患者RASSF1A基因甲基化比例（23.1%）明显高于髓系白血病患者（6.4%）（P＜0.05）。结论　白血病患者骨髓中存在RASSF1A基因甲基化，淋巴系白血病甲基化比例明显高于髓系白血病。RASSF1A基因甲基化检测可能成为白血病分型的生物标志物之一。

Abstract: Objective　To research Ras association domain family 1A（RASSF1A） gene promoter region methylation in bone marrow of leukemia patients and its clinical significance. Methods　Methylation of RASSF1A gene promoter region was detected by methylation specific polymerase chain reaction（MS-PCR） in the bone marrow of 86 leukemia patients，and the difference of different kinds of leukemia was analyzed. A total of 60 non-leukemia subjects were enrolled as controls. Results　Twelve of 86（13.95%） leukemia patients had RASSF1A gene promoter region methylation. No methylation was found in bone marrow of the control group，and there was a statistical significance（P＜0.05）. RASSF1A gene methylation ratio in lymphoid leukemia（23.1%） was higher than that in myeloid leukemia（6.4%）（P＜0.05）. Conclusions　Leukemia patients have RASSF1A gene methylation. The ratio of RASSF1A gene methyaltion in lymphoid leukemia is obviously higher than that in myeloid leukemia. RASSF1A gene methyaltion may be a significant parameter for diagnosis and genotyping of patients with leukemia.

Key words: Ras association domain family 1A gene, Leukemia, Methylation, Biomarker

陈卫群;黄　琛;詹喜炎;刘水逸;余　洁;张红梅;卢忠心. 白血病患者RASSF1A基因甲基化状态及其临床意义[J]. 检验医学, 2012, 27(7): 554-556.

CHEN Weiqun;HUANG Chen;ZHAN Xiyan;LIU Shuiyi;YU Jie;ZHANG Hongmei;LU Zhongxin . RASSF1A gene methylation and its clinical significance in leukemia patients[J]. , 2012, 27(7): 554-556.

参考文献

[1]Dunwell T，Hesson L，Rauch TA，et al. A genome-wide screen identifies frequently methylated genes in haematological and epithelial cancers [J]. Mol Cancer，2010，9：44.
[2]Richter AM，Pfeifer GP，Dammann RH. The RASSF proteins in cancer；from epigenetic silencing to functional characterization [J]. Biochim Biophys Acta，2009，1796（2）：114-128.
[3]Kurkjian C，Kummar S，Murgo AJ. DNA Methylation：its role in cancer development and therapy[J]. Curr Probl Cancer，2008，32（5）：187-235.
[4]Wang J，Wang B，Chen X，et al. The prognostic value of RASSF1A promoter hypermethylation in non-small cell lung carcinoma：a systematic review and meta-analysis [J]. Carcinogenesis，2011，32（3）：411-416.
[5]Hu L，Chen G，Yu H，et al. Clinicopathological significance of RASSF1A reduced expression and hypermethylation in hepatocellular carcinoma [J]. Hepatol Int，2010，4（1）：423-432.
[6]Wang T，Liu H，Chen Y，et al. Methylation associated inactivation of RASSF1A and its synergistic effect with activated K-Ras in nasopharyngeal carcinoma [J]. J Exp Clin Cancer Res，2009，28：160.
[7]Kang S，Kim HS，Seo SS，et al. Inverse correlation between RASSF1A hypermethylation，KRAS and BRAF mutations in cervical adenocarcinoma [J]. Gynecol Oncol，2007，105（3）：662-666.
[8]Ma L，Guo Q，Ma Y，et al. Clinicopathological implications of inactivation of RASSF1A in serous epithelial ovarian cancers [J]. Eur J Gynaecol Oncol，2009，30（4）：370-374.
[9]Martins AT，Monteiro P，Ramalho-Carvalho J，et al. High RASSF1A promoter methylation levels are predictive of poor prognosis in fine-needle aspirate washings of breast cancer lesions [J]. Breast Cancer Res Treat，2011，129（1）：1-9.
[10]Harada K，Toyooka S，Maitra A，et al. Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines[J]. Oncogene，2002，21（27）：4345-4349.
[11]Johan MF，Bowen DT，Frew ME，et al. Aberrant methylation of the negative regulators RASSFIA SHP-1 and SOCS-1 in myelodysplastic syndromes and acute myeloid leukaemia[J]. Br J Haematol，2005，129（1）：60-65.
[12]Avramouli A，Tsochas S，Mandala E，et al. Methylation status of RASSF1A in patients with chronic myeloid leukemia[J]. Leuk Res，2009，33（8）：1130-1132.